Brief: Merus NV Reports Quarterly Loss Per Share Of $0.53

Merus NV

03/11/2022 11:59

Nov 3 (Reuters) - Merus Nv  MRUS.O :
    * MERUS ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER
AND
PROVIDES BUSINESS UPDATE
    * CLINICAL UPDATE OF PETOSEMTAMAB PLANNED FOR FIRST HALF OF
2023
    * QTRLY LOSS PER SHARE $0.53
    * CASH RUNWAY, MERUS EXPECTS TO BE FUNDED BEYOND 2024
    * Q3 EARNINGS PER SHARE VIEW $-0.63 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7DbDGR 
Further company coverage:  MRUS.O 
 ((Reuters.Briefs@thomsonreuters.com;;))